Connect Biopharma is trading at $1.06, down 38.7% after closing at $1.73 on September 14, 2026; no clear company-specific announcement explains the September 15 decline.
- Management is scheduled for an H.C. Wainwright fireside chat at 11:30 a.m. EDT.
- Broader markets are only modestly lower, so macro weakness does not clearly explain this move.